Skip to main content

Investors Grab OVID 25.0% Cheaper Than Its Secondary Stock Offering

Looking back to 92 days ago, Ovid Therapeutics Inc (OVID) priced a 6,250,000 share secondary stock offering at $8.00 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.